Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Robinhood Markets, Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Robinhood Markets, Inc. trades at $98.75 (market cap $90.88B). The key difference: Robinhood Markets, Inc. is far larger — about 10.7× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Robinhood Markets, Inc. for 75 Days on average.
| HNGE | HOOD | |
|---|---|---|
Market Cap | $8.47B | $90.88B |
Volume | 1,624,526 | 23,337,832 |
Sector | Health | Financials |
52-Week High | $105.14 | $147.08 |
52-Week Low | $31.17 | $65.16 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $8.09B | $97.42B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Robinhood (HOOD) trades at $110.52, up 1.19% with a neutral technical signal. The company shows strong fundamentals with 2025 revenue of $4.47B and net income of $1.88B, though valuation metrics remain elevated (P/E 48.9, P/S 20.61). Recent news highlights expansion into 24/7 trading and AI-powered features, while earnings show mixed quarterly performance with two beats and one miss in the last four quarters.
Analyst consensus remains bullish with 74% buy ratings and a $138.60 price target, representing 25% upside potential. Key risks include high valuation multiples, competitive pressures in online brokerage, and regulatory scrutiny. The company's transformation into a broader financial services platform provides growth opportunities but requires careful execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
